Diagnosing malignant pleural effusion with the EPISEEK-MPE liquid biopsy
Official title: Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
Run by University of Arizona · NCT07929584 · Data updated 2026-11-12
A test called EPISEEK-MPE is being checked to see if it can tell cancer from non-cancer pleural effusions using fluid already removed for care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 625 (estimated) |
| Sponsor | University of Arizona Academic / other |
| Locations | 2 sites (Tucson, Arizona and 1 other locations) |
| Status | Recruiting |
| Started | January 8, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | May 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07929584 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with pleural fluid drained for clinical care who consent to use of their fluid for research.
✕Probably not a fit
Patients with insufficient pleural fluid after drainage or who do not consent to data/sample use may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multi-site validation study evaluates the EPISEEK-MPE liquid biopsy assay as a diagnostic aid for malignant pleural effusions. Researchers compare the test’s results with standard clinical information and patient records to determine reliability across age, race, gender, and ethnicity. The study uses excess pleural fluid from routine drainage and collects medical-record data to assess diagnostic performance and potential survival associations. It aims to establish the EPISEEK-MPE test as a complementary tool to cytology in differentiating malignant from benign effusions.
Why it matters
Potential benefit: If successful, this test could improve accuracy in diagnosing malignant pleural effusions and help guide treatment decisions.
How similar studies have gone: Preliminary work suggests epigenetic liquid biopsy approaches can add diagnostic value in pleural effusions, but this specific multi-site validation is ongoing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients having pleural fluid drained for clinical care (thoracentesis or chest tube placement) * Consent to have pleural fluid sample used for research Exclusion Criteria: \- Insufficient fluid available following clinical drainage procedure
Where it's running
-
Banner University Medical Center South
Tucson, Arizona, United States Recruiting -
Banner University Medical Center Tucson
Tucson, Arizona, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating saline irrigation for treating retained pleural infections
This study is testing if adding saline irrigation to standard treatment can help people with retained pleural infections feel better and recover faster.
-
Evaluating ultrasound-guided pleural drainage in ICU patients with respiratory failure
This study is testing if using ultrasound to help drain fluid from the lungs can improve the health of adults in the ICU who are struggling to breathe.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Apixaban vs Warfarin for a Left Ventricular Thrombus
This study tests whether apixaban can more conveniently and safely dissolve a left ventricular blood clot compared with warfarin.
-
Breathing for Two: Can inspiratory muscle training help with blood pressure in late pregnancy?
This study tests whether a home-based inspiratory muscle strength training program can safely lower blood pressure in pregnant people in their third trimester.
-
Comparative test of PAP therapy, a dental device, and atomoxetine-oxybutynin for adults with obstructive sleep apnea
This study tests three options for obstructive sleep apnea to see which works best and is easiest for patients to use.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.